Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1998-08-28
1999-11-23
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514552, 514863, 514168, A61K 31595
Patent
active
059901004
ABSTRACT:
Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
REFERENCES:
patent: 4316902 (1982-02-01), Yu et al.
patent: 4495203 (1985-01-01), Grollier et al.
patent: 4496588 (1985-01-01), Bey et al.
patent: 4507321 (1985-03-01), Raisfeld
patent: 4513011 (1985-04-01), Grollier et al.
patent: 4518789 (1985-05-01), Yu et al.
patent: 4626529 (1986-12-01), Grollier
patent: 4837213 (1989-06-01), Caron et al.
patent: 4847257 (1989-07-01), Hupe et al.
patent: 4892888 (1990-01-01), Grollier et al.
patent: 4933330 (1990-06-01), Jorgensen et al.
patent: 4981681 (1991-01-01), Tosti
patent: 5681835 (1997-10-01), Willson
"Psoriasis Patients Try the Alternatives", Skin & Allergy News, vol. 28, No. 3, dated prior to Mar. 18, 1997, pp. 1 & 25.
1997 CIR Compendium, Cosmetic Ingredient Review, Washington, D.C., 1997, p. 97.
Program Bulletin for Joint Meeting, 5th European Congress on Psoriasis, 7th International Psoriasis Symposium, received Aug. 17, 1998, p. 24 Paragraph Pl.
Federal Register, vol. 47, No. 233, Part IV, Department of Health and Human Services, FDA, OTC Drug Products for the Control of Dandruff, Seborrheic Dermatitis, and Psoriasis; Establishment of a Monograph, Dec. 3, 1982, pp. 54646-54684.
"A Super-Effective Natural Therapy for Psoriasis", Health & Healing, vol. 7, No. 2, By Dr. Julian Whitaker, Feb. 1997, pp. 4-5.
The Schoch Letter, vol. 47, No. 4, Editor: Ervin Epstein, Apr. 1997, Paragraphs 49, 50.
Kragballe Pharmacol. Toxicol. (Copenhagen), 77 (4), 241-6 (Abstract), 1995.
Glenn Thomas M.
Noah Patricia W.
Rosenberg E. William
Skinner, Jr. Robert B.
Panda Pharmaceuticals, L.L.C.
Reamer James H.
The University of Tennessee Research Corporation
LandOfFree
Composition and method for treatment of psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for treatment of psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treatment of psoriasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222045